Commitment of Members
As members of The University of Chicago Medicine Comprehensive Cancer Center, we are committed to exploring and developing innovative ways to prevent and reduce the devastating effects of cancer. Although we recognize that we may never find a universal cure for all cancers, we are dedicated to transforming this deadly disease into a chronic ailment. To meet this ambitious challenge, we focus on:
Meeting the Needs of Our Patients
- Stimulate and support collaborative, interdisciplinary basic and clinical cancer research, and bring the benefits of our breakthroughs to patients to provide them with superior, state-of-the-art care;
- Pioneer preventative strategies based on cutting-edge research;
- Develop and provide imaging techniques and technologies to enhance diagnostics, detect malignancies early in their development, and improve the accuracy of radiographs; and
- Improve quality of life for patients and provide convenient access to useful resources to support their physical, social, and emotional needs.
Performing Research of the Highest Quality
- Use clinical trials to test investigational drugs and identify effective new cancer therapies; and
- Apply the latest advances in imaging, molecular biology, information technology, genetics, genomics, systems biology, and other disciplines to the study of human cancer.
Supporting Local Physicians and Providing Enhanced Education for Health Professionals
- Provide education and training for basic scientists, clinical investigators, and healthcare professionals at all levels;
- Ensure clinical trial access to community oncologists and minority populations via a network of affiliated hospitals and health centers; and
- Develop and implement outreach programs that educate local health professionals about new treatment, prevention, and diagnostic techniques.
Strengthen Links with the Communities We Serve
- Enable sustained engagement with our community to increase public awareness of advances in cancer research;
- Communicate the benefits of participating in cancer clinical trials; and
- Implement new cancer prevention and control research studies.